首页> 外文OA文献 >Bortezomib plus dexamethasone results in a late organ response in primary heavy-chain amyloidosis without a hematologic response

【2h】

Bortezomib plus dexamethasone results in a late organ response in primary heavy-chain amyloidosis without a hematologic response

机译：硼替佐米加地塞米松可导致原发性重链淀粉样变性的晚期器官反应，而无血液学反应

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Hassoun Yasmin; Kharfan-Dabaja Mohamed A.; Baz Rachid;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Bortezomib plus dexamethasone results in a late organ response in primary heavy-chain amyloidosis without a hematologic response [J] . Yasmin Hassoun, Mohamed A. Kharfan-Dabaja, Rachid Baz Hematology/Oncology and Stem Cell Therapy . 2015,第3期

机译：硼替佐米加地塞米松可导致原发性重链淀粉样变性的晚期器官反应，而无血液学反应
2. Rapid Hematologic and Organ Responses with Daratumumab, Bortezomib and Dexamethasone in Patients with Relapsed/Refractory AL Amyloidosis [J] . Lee Sarah S., Rosko Nathaniel, Patel Bhumika J., Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：用甘露渣，硼替佐米和地塞米松的快速血液学和器官应对患者复发/难治性Al淀粉样蛋白病
3. Combined use of bortezomib, cyclophosphamide, and dexamethasone induces favorable hematological and organ responses in Japanese patients with amyloid light-chain amyloidosis: a single-institution retrospective study [J] . Kikukawa Yoshitaka, Yuki Hiromichi, Hirata Sinya, International journal of hematology . 2015,第2期

机译：硼替佐米，环磷酰胺和地塞米松的联合使用在日本淀粉样蛋白轻链淀粉样变性患者中诱导良好的血液学和器官反应：单机构回顾性研究
4. EXTENT OF HEMATOLOGIC RESPONSE IS IMPORTANT IN DETERMINING OUTCOME IN TRANSPLANTED PATIENTS WITH PRIMARY SYSTEMIC AMYLOIDOSIS. IMPORTANCE OF ACHIEVING A COMPLETE RESPONSE [C] . SR. Hayman, MQ Lacy, A Dispenzieri, International Symposium on Amyloidosis . 2008

机译：血液学反应程度对于确定移植患者的原发性全身淀粉样蛋白病的结果是重要的。实现完整响应的重要性
5. Improving Indwelling Glucose Sensor Performance: Porous, Dexamethasone-Releasing Coatings that Modulate the Foreign Body Response. [D] . Vallejo-Heligon, Suzana Gabriela. 2015

机译：改善留置血糖传感器的性能：疏松地塞米松的多孔涂层，可调节异物反应。
6. Cyclophosphamide-bortezomib-dexamethasone (CyBorD) produces rapid and complete hematologic response in patients with AL amyloidosis [O] . Joseph R. Mikhael, Steven R. Schuster, Victor H. Jimenez-Zepeda, -1

机译：环磷酰胺-硼替佐米-地塞米松（CyBorD）对AL淀粉样变性患者产生快速而完整的血液学反应
7. Maintained Hematologic and Organ Responses Following Risk Adapted Stem Cell Transplant (SCT) in Systemic Light-Chain Amyloidosis (AL) Using Bortezomib and Dexamethasone as Consolidation Therapy [O] . Landau H.J., Hassoun H., Rosenzweig M.A., 2012

机译：使用硼替佐米和地塞米松作为巩固疗法，在全身轻链淀粉样变性病（AL）中进行风险适应性干细胞移植（SCT）后，维持血液学和器官反应
8. Dexamethasone Suppresses ACTH Release Without Attenuating Pituitary Cyclic AMP Response to Stress In Vivo. [R] . Kant, G. J., Mougey, E. H., Brown, A. J., 1989

机译：地塞米松抑制aCTH释放而不会减弱垂体环amp对体内应激的反应。

Bortezomib plus dexamethasone results in a late organ response in primary heavy-chain amyloidosis without a hematologic response

著录项

引文网络

相似文献

相关主题

期刊订阅